Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION - Narrative (Details)

v3.22.1
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 28, 2022
Mar. 31, 2022
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock based compensation expenses   $ 152  
Cost not yet recognized   $ 3,735  
Period for cost yet to be recognized   2 years 2 months 8 days  
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   4 years  
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cost not yet recognized   $ 46,922  
Period for cost yet to be recognized   2 years 9 months 3 days  
Weighted average grant date fair value (usd per share)   $ 6.60  
Vested (in shares)   0  
Forfeited (in shares)   18,153  
TV Squared      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Issued, fully vested stock option (in shares) 949,893 949,893  
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period   10 years  
Minimum | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   3 years  
Maximum | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period   4 years  
Employees | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options, grants in period (in shares)   7,113,780  
Consultants      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock based compensation expenses   $ 29 $ 19
Consultants | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options, grants in period (in shares)   169,287